Opendata, web and dolomites

BQ-Technology

BrainQ, non-invasive, very low intensity, BCI-based frequency dependent electromagnetic field tailored treatment for neuro recovery (BQ).

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BQ-Technology project word cloud

Explore the words cloud of the BQ-Technology project. It provides you a very rough idea of what is the project "BQ-Technology" about.

patient    55    neural    spectral    efficacy    sensor    algorithms    first    attributable    anomalous    treat    death    impaired    regain    agnostic    patients    mortality    functional    living    daily    stroke    time    easily    stimulation    burden    proprietary    patterns    perform    designed    clinical    deficits    bill    infections    scalable    skills    invasive    prevalence    natural    decreased    triggers    indication    neuro    impairments    remarkable    dementia    frequency    world    globally    device    sensorimotor    rehabilitation    risk    dependent    paralysed    cognitive    treatment    materials    artificial    network    continue    operator    age    demonstrated    viral    eeg    electromagnetic    disorders    waves    healthcare    bq    revolutionary    global    recovery    injuries    restore    operated    care    back    decade    causes    aging    frequencies    feet    linked    doubles    interface    trials    intelligence    uses    brain    populations    animal    neurological    translated    computer    human    brainq    cloud    strokes    disability    connected    variety    motor   

Project "BQ-Technology" data sheet

The following table provides information about the project.

Coordinator
BRAINQ TECHNOLOGIES LTD 

Organization address
address: 4/4 HIGH TECH VILLAGE GIVAT RAM
city: JERUSALEM
postcode: 39129
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://brainqtech.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BRAINQ TECHNOLOGIES LTD IL (JERUSALEM) coordinator 50˙000.00

Map

 Project objective

The WHO has identified neurological disorders as a major burden and emerging challenge to global healthcare systems. These range from causes such as stroke and dementia, to injuries and viral infections. The prevalence of strokes and dementia are strongly linked to increasing age, for example stroke risk more than doubles every decade after 55 . Although, mortality attributable to stroke has decreased over time Stroke remains a leading cause of death and disability globally and can cause significant deficits in sensorimotor skills and cognitive abilities.

With the increasingly aging populations across the world and particularly in Europe, the burden of care from Neurological disorders is set to continue increasing.

BrainQ’s BQ system is a revolutionary Brain Computer Interface-based stimulation device used to enhance neuro-recovery. Our device uses proprietary, artificial intelligence algorithms to identify anomalous spectral patterns in patient's brain waves (“EEG”). These patterns are then translated into a tailored frequency dependent electromagnetic treatment targeting specific impaired functional neural network associated with these frequencies and triggers natural rehabilitation thus promoting neuro recovery process.

Device is designed to enable non-invasive treatment for motor impairments following a variety of neurological disorders; help patients get back on their feet and restore their ability to perform activities of daily living. Treatment is tailored to each patient, is patient friendly, non-invasive, cloud connected & scalable, with low Bill of Materials, and operator & indication agnostic. This means it is easily operated and can be used to treat a variety of neurological disorders. Pre-clinical animal trials and first-in-human clinical trials have demonstrated remarkable efficacy, allowing paralysed patients regain sensor and motor abilities.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BQ-TECHNOLOGY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BQ-TECHNOLOGY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Skye (2018)

Redefining Drone Safety and Autonomous Operation for Indoor Commercial Applications

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More